Company Info

VascuFlo, Inc. The EECP® treatment centers of Western New York opened for treatment on July 10th, 2002 our treatment hours are from 7:00 am until 5:00 pm Monday thru Friday. We are closed all weekends and major holidays . To contact us please call
(716) 681-2968 or by E-mail at:
ahirsch@vascuflo.com.

We look forward to serving you in the future.

The EECP® Heart Centers of Western New York Central Office Location is at:
2470 Walden Ave Suite 300
Cheektowaga, NY, 14225
Tel: (716) 681-2968

VascuFlo, Inc. strives to make our treatment centers comfortable. The waiting area and treatment rooms have cable television. Most patients read, watch TV, listen to music and sometimes even fall asleep during their one-hour treatment.

Hear about EECP® and VascuFlo Inc.

VascuFlo’s Mission & Vision Statement.

VascuFlo, Inc. was established in 2001 by Aaron Hirsch, RPh. under the Medical Direction of Dr. Michael E. Merhige and Dr. Leon Levinsky. EECP treatment was approved by the Food and Drug Administration (FDA) for the treatment of angina pectoris in 1995 and for the treatment of congestive heart failure in 2002. Currently there are over 1000 EECP treatment centers nationally and many others worldwide. VascuFlo was the first EECP center to treat patients in Western New York.

VascuFlo is the forerunner in providing EECP treatment within the setting of 4 private practices in Western New York, Niagara Falls and Irving.

With great anticipation we look forward to other physicians and medical groups offering EECP treatment to the patients of Western New York to provide all of those in need.

VascuFlo Vision Statement:

To be recognized as professional, dedicated, and to help revolutionize cardiovascular care by emphasizing compassion, empathy, and the utilization of new technology.

VascuFlo Mission Statement:

VascuFlo exists to provide exceptional quality care. We are committed to creating a positive experience for our patients who undergo EECP treatment. We promote optimal health and quality of life by providing a highly successful cost effective treatment.

EECP is a registered trademark of Vasomedical, Inc. © 2008 Vasomedical, Inc.

Website hosting provided by Online Media, Inc.